Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients
Clinical trial NCT02706249 · COMPLETED
Trial details
- NCT number
- NCT02706249
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2020-12-07
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.